Washington, DC—(ENEWSPF)—February 6, 2015. Medical device manufacturer Medtronic Inc. has agreed to pay the United States $2.8 million to resolve allegations under the False Claims Act that Medtronic caused certain physicians to submit false claims to federal health care programs for a medical procedure known as “SubQ stimulation,” the Justice Department announced today. Medtronic Inc. is a medical technology company based in Minnesota.
“Today’s settlement demonstrates our commitment to ensure that beneficiaries of federal health…
